Skip to content

Comparative analysis of the effectiveness and security of the blockade Erectus Spinae Plane Lumbar (ESP-L) versus the absence of locoregional block in hip surgery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-511528-15-00
Enrollment
170
Registered
2024-05-27
Start date
2024-06-02
Completion date
2025-05-08
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture

Brief summary

To compare the analgesic efficacy and safety of lumbar ESP block versus the absence of blockade in the postoperative period of hip and proximal femur surgery through the VAS scale with pain reduction of at least 1 point after two hours postoperative.

Detailed description

- Compare postoperative analgesic needs after performing the block ESP-L versus control group of patients undergoing hip or femur surgery proximal - Compare postoperative opioid consumption in the two groups. - Assess and compare the technical ease of the intervention (ESP-L block) - Compare the side effects in the two lines of treatment - Assess the level of patient satisfaction

Interventions

DRUGLevobupivacaina Kabi 2
DRUG5 mg/ml soluzione iniettabile/per infusione

Sponsors

Asociacion Gallega De Anestesiologia Reanimacion Y Dolor
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
To compare the analgesic efficacy and safety of lumbar ESP block versus the absence of blockade in the postoperative period of hip and proximal femur surgery through the VAS scale with pain reduction of at least 1 point after two hours postoperative.

Secondary

MeasureTime frame
- Compare postoperative analgesic needs after performing the block ESP-L versus control group of patients undergoing hip or femur surgery proximal - Compare postoperative opioid consumption in the two groups. - Assess and compare the technical ease of the intervention (ESP-L block) - Compare the side effects in the two lines of treatment - Assess the level of patient satisfaction

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026